Send me a link:

*Text messaging rates may apply.

 Dow Down1.88% Nasdaq Down2.09%

Nektar Therapeutics (NKTR)

-NasdaqGS
10.55 Down 0.46(4.18%) 4:00PM EDT
|After Hours : 10.55 0.00 (0.00%) 5:04PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue 19,771   31,146   60,909   33,862  
Cost of Revenue7,907  8,960  12,877  5,011  
Gross Profit 11,864   22,186   48,032   28,851  
Operating Expenses
Research Development38,338  48,248  43,914  52,230  
Selling General and Administrative9,928  9,832  10,643  9,228  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (36,402) (35,894) (6,525) (32,607)
Income from Continuing Operations
Total Other Income/Expenses Net312  100  378  205  
Earnings Before Interest And Taxes(36,090)(35,794)(6,147)(32,402)
Interest Expense9,920  10,230  10,203  10,141  
Income Before Tax(46,010)(46,024)(16,350)(42,543)
Income Tax Expense191  1,635  193  205  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(46,201)(47,659)(16,543)(42,748)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (46,201) (47,659) (16,543) (42,748)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (46,201) (47,659) (16,543) (42,748)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.